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1. Introduction
  Infectious diseases are persisting as a major health problem for 
almost half a century now and there has been increasing incidence 
of resistance to currently available antibacterials [1]. There is the 
need for intensive studies for possible discovery of new agent 
with antibacterial potentials. Many drugs have been discovered 
by the exploitation of traditional medicine since the early dates of 
human existence[2]. In ethnomedicine, the plant, Stachytarpheta 
cayennensis has been reported to have the following activity; 
vermifuge [3], sedative and anxiolytic [4], anti-inflammatory 
and analgesics [5], as well as anti-diarrhea [6]. Other 
documented ethnomedicinal uses include asthma, itching, 
sores, boils, intestinal parasite, neuralgia, and eczema, 
cough and venereal diseases [7], as well as antiulcer [8] and 
anticonvulsant[9]. Due to the popularity of this plant in folk 
medicine, we were prompted to investigate the antimicrobial 
and antispasmodic activities of its leaf extracts and fractions 
using in vitro models.
2. Materials and methods
2.1. Plant material
  Fresh leaves of S. cayennensis were collected in July 2006 
from Nsukka, Enugu State, Nigeria and authenticated 
by Mr. A. Ozioko of Bioresources Development and 
Conservation Programme (BDCP) Center, Nsukka.  The 
leaves were cleaned, dried under the sun and pulverized 
to coarse powder using laboratory mill (Thomas Willey, 
Model 4).  The powdered leaves (400 g) were extracted with 
methanol by cold maceration for 48 hours [10]. The filtrate 
was concentrated in a rotary evaporator under reduced 
pressure to obtain the methanol extract (ME: 103 g; 25.75% 
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w/w).  The extract (30 g) was partitioned with n-hexane, 
ethyl acetate and methanol in order of increasing polarity. 
The n-hexane, ethylacetate and methanol fractions were 
also concentrated in a rotary evaporator under reduced 
pressure, and afforded 4.3 g of the n-hexane fraction (HF; 
1.1% w/w), 6.7 g of the ethyl acetate fraction (EF;  1.7% 
w/w) and 35.6 g of the methanol fraction (MF; 8.90% w/
w).  The extract and fractions were tested for activity 
and subjected to phytochemical analysis using standard 
methods [10, 11]. 
2.2. Animals
  Guinea pigs (250-500 g) bred in the Laboratory Animal 
Facility of the Department of Pharmacology and Toxicology, 
University of Nigeria, Nsukka, were used in the studies. 
The animals were maintained under standard laboratory 
conditions and had free access to standard pellets (Guinea 
Feeds, PLC, Nigeria.) and water.
2.3. Microorganisms
  Clinical microbial isolates namely Escherichia coli, 
Bacillus substilis, Pseudomonas aeruginosa, Salmonella 
paratyphi, Staphylococcus aureus, Aspergillus niger and 
Candida albicans, obtained from the Microbiology Unit 
of the Department of Pharmaceutics and Pharmaceutical 
Microbiology, University of Nigeria, Nsukka, were used.
2.4. Antimicrobial assay
  500 mg each of the extract and fractions (ME, HF, EF 
and MF) were dissolved in 5 mL of dimethyl sulfoxide 
(DMSO) by shaking to obtain 100 mg/mL concentration. 
Subsequently, the concentration was diluted to obtain 50 
mg/mL and 25 mg/mL for the determination of the minimum 
inhibitory concentration (MIC) at the dose levels. Agar well 
diffusion method [12, 13] was employed for the assay. A 0.5 
Marcfaland standard was used in the preparation of the 
organisms used to seed the agar plates. The test organisms 
were sub-cultured at 37 ℃ and maintained on nutrient 
agar media for bacteria and sabouraud agar medium for 
fungi. Petri dishes containing 20 mL of respective medium 
were seeded with selected microbial strains which were 
incubated at 37 ℃ for 24 hours. Standard antimicrobial 
agents used as positive controls were; ampicillin (Elvis 
Pharm.), gentamycin (Lek, Slovakia), ciprofloxacin 
(Medriech, India) and tetracycline (NASSMU, Lagos). 
After 24 hours the inhibition zone diameters (IZD) were 
recorded and the mean calculated. The minimum inhibitory 
concentration (MIC), was then determined at various 
dilutions by extrapolation from the graphs of IZD squared 
(IZD2) against logarithm of the concentration.
2.5. Antispasmodic effect
  A modified method described by Mukherjee [14] was 
adopted for the antispasmodic effect. A segment of the 
guinea pig ileum (about 2 cm) was suspended in a 50 
mL organ bath containing Tyrode solution maintained at 
(36±1) ℃ and connected with an aerator.  The tissue 
was allowed to equilibrate for 30 minutes under a resting 
tension of 0.5 g before exposure to drugs and extracts. 
During equilibration period, the tissue was washed 
with fresh Tyrode solution every 10 minutes to prevent 
the accumulation of metabolic end products [15]. Non-
cumulative dose responses to acetylcholine and histamine 
were established. The effects of the extract and fractions 
on the responses elicited by these agonists were recorded. 
The responses were recorded via a frontal writing lever on 
kymograph paper (Scientific and Research Instruments 
Ltd., England).  The responses were repeated three times 
and mean percentage inhibition calculated.
3. Results
3.1. Phytochemical constituents of the extract and fractions
  Phytochemical screening revealed the presence of 
saponins, carbohydrates, flavonoids and terpenoids in 
all the extract and fractions. Saponins had the highest 
abundance, whereas alkaloids, steroids, reducing sugars 
and glycosides were significantly present in the methanol 
extract and fractions (Table 1).
Table 1
Phytochemical constituents of the extracts and fractions.
Constituent ME HF EF MF
Carbohydrates +++ + ++ ++
Reducing sugar + - - +
Glycosides + - - +
Flavonoids + + ++ +
Saponins +++ +++ ++ +++
Alkaloids ++ - - ++
Terpenoids ++ + ++ +
Steroids ++ - - +
+++ = Conspicuously present; ++ = moderately present; + = present; 
- = absent.
3.2. Antimicrobial assay
  The result indicated that both the extract and fractions 
possessed significant antibacterial  activity with 
insignificant anti-fungal activity. The result of inhibition 
zone diameter (IZD) and MIC revealed a dose dependent 
potency in antibacterial activity. The n-hexane fraction 
inhibited the growth of only B. subtilis organism whereas 
all the other fractions and the extract exhibited certain level 
of inhibition on all the other bacterial strains tested (Tables 
2 and 3).
3.3. Antispasmodic effects
  The findings showed that the extract and fractions did not 
evoke contraction of the guinea pig ileum at concentrations 
tested. However, they exhibited dose-dependent inhibition 
of contractions induced by acetylcholine (Ach) and 
histamine (H), on the isolated guinea pig ileum.  The 
ethyl acetate fraction (EF) was the most potent while the 
methanol extract (ME) indicated the least inhibitory effects 
(Table 4, Figure 1 and Figure 2).  
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Table 4
Concentrations of extract and fractions at 50% inhibition of maximal 
response exhibited by acetylcholine and histamine. 
Extract/Fraction






Figure 1. Effects of extract and fractions on acetylcholine induced 
contractions on isolated guinea pig ileum.
Figure 2. Effects of extract and fractions on histamine induced 
contractions on lsolated guinea pig ileum.
4. Discussion
  The antimicrobial screenings showed that the extracts 
exhibited antibacterial activity against various gram-
negative and gram-positive organisms but are devoid 
of significant fungistatic activity.  The order of bacterial 
susceptibility was B-subtilis> Staph aureus>Ps. aeruginosa 
>Sal. paratyphi. The minimum inhibitory concentration 
data indicated that the antibacterial activity of the extracts 
and fractions was comparable to the standard antibiotics 
Table 2 
Inhibition zone diameter (IZD) of extract and fractions of S. cayennensis.
HF EF MF ME SA (滋g/mL)
100 50 25 100 50 25 100 50 25 100 50 25 A T G
B. Subtilis 5.0 4.5 4.0 9.0 6.0 4.5 4.0 3.5 3.0 5.0 4.0 3.0 9.0 11.0 26.0
Staph aereus + + + 8.0 5.0 4.0 6.0 5.0 4.0 6.0 3.0 2.0 20.0 + 26.0
Ps. Aeruginosa + + + 4.5 4.0 3.0 6.0 3.0 + 4.0 3.0 + 8.0 16.0 22.0
Sal. Paratyhpi + + + 4.5 3.5 3.0 4.0 3.0 + 5.0 4.5 4.0 9.0 17.0 20.0
C. albican + + + + + + + + + + + + - - -
 HF = n-Hexane fraction, EF= Ethylacetate fraction, MF=Methanol fraction, ME= Methanol extract, + = no significant inhibition, SA= Standard 
antibiotics used. Concentrations of extracts and fractions in mg/mL, all IZD figures are in mm, A= ampicillin, T= tetracycline and G= gentamycine. 
Table 3 
The minimum inhibitory concentration (MIC) of extract an fractions (mg/mL).
Microorganism HF EF MF ME AMP TETRA GENT
B. subtilis 1.07 1.25 3.98 5.62 5.62 1.33 0.02
Staph. aureus - 6.30 8.81 14.12 1.00 - 0.23
Ps. aeruginosa - 9.40 39.80 22.38 12.50 2.51 1.77
Sal. paratyphi - 9.40 21.13 2.11 22.38 1.67 0.79
HF = nHexane fraction, EF = Ethylacetate fraction, MF = Methanol fraction, ME = Methanol extract, AMP = Ampicillin, TETRA = 
Tetracycline, GENT = Gentamycin.
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employed in the study. The antibacterial activity could be 
attributed to the effects of bioactive phytochemical constituents 
such as flavonoids, saponins and terpenoids [16, 1, 10]. The 
phytochemical studies indicated highest concentration of 
terpenoids and flavonoids in EF. There is the possibility 
that these constituents might be responsible for the most 
potent antibacterial effect exhibited by EF. The result of 
the antibacterial study tends to support the ethnomedicinal 
use of S. cayennensis in the treatment of sores, boils and 
venereal diseases [7]. It also highlights the potential wound 
healing activity, since P. aeruginosa and Staph aureus are 
among microbial agents that are often associated with the 
progression of wounds and sores of diverse etiology [17]. The 
extract and fractions exhibited significant dose dependent 
inhibition of contractions induced by Ach and histamine on 
isolated guinea pig ileum.  Histamine and acetylcholine are 
important endogenous spasmogens and agents that inhibit 
their contractions may have a good antispasmodic potential. 
There is an indication of a non-specific antagonism by 
the extracts [18]. This antagonism could either be through 
the receptor site such as the muscarinic and histaminic 
receptors or through other musculotropic route such as influx 
or out flux of calcium ions [19]. The ethylacetate fraction, 
which exhibited the most potent inhibition of contractions 
induced by the spasmogens, contains highest concentration 
of flavonoids bioactive constituents as depicted by the 
phytochemical studies. Though these effects may not be 
categorically been assigned to a particular constituents at 
this level, but flavonoids have variously been implicated and 
demonstrated to inhibit guinea pig ileal contraction induced 
by some spasmogens[20, 21]. The antispasmodic activity of the 
extract and fractions has further highlighted the potential 
antiulcer activity of the extracts of S. cayennensis[8]. 
These results showed that the extract and fractions of S. 
cayennensis possessed broad spectrum antibacterial activity 
with potent spasmolytic effect. 
Conflict of interest statement
  We declare that we have no conflict of interest.
References
[1]Subashini HD, Rajam A, Malarvannan S, Sekar S, Varsha R. 
Antimicrobial properties of Dodonaea angustifolia against human 
pathogens. J Trop Med Plant 2006; 7(2):157-159.
[2]Nwaogu MA, Insight into herbal medicine: An approach to a 
healthier life. Okigwe : Whytem Publishers, Nigeria;1997,p.1-5.
[3]Dragendorff  G. Dei Heilpflanzen Der Verschiedenen Volker Und 
Zieten. Stuttgart: Ferdinand Enke;1898, p. 885.
[4]Akanmu MA, Olayiwola G, Ukponmwan OE, Honda K. Acute 
Toxicity and sleep wake EEG Analysis of Stachytarpheta cayennensis 
in rodents. Afr J Trad CAM 2005;2(3):222-32.
[5]Schapova EE, Vargas MR, Caves CG. Antiinflammatory and 
antinociceptive activities of extracts and isolated compounds from 
Stachytarpheta cayennensis. J Ethnopharmacol 1998;60(1):53-9.
[6]Almeida CE, Karnikowaski MG, Foleto R, Baldisserotto B. Analysis 
of antidiarrhoeic effect of plants used in popular medicine. Rev Saude 
Publica1995;26(6):428-33.
[7]Leslie T. The healing power of rainforest herbs: A guide to 
understanding and using herbal medicinals. New York: Squareone 
Publisher; 1996,p.140-50. 
[8]Vela SM, Souccar C, Lima-Landman MT, Lapa AJ. Inhibition of 
gastric acid secretion by the aqueous extract and purified extract of 
Stachytarpheta cayennensis. Planta Med 1997;63(1):36-9.
[9]Okoye TC, Aguwa CN, Okoli CO, Akah PA, Nworu CS. 
Anticonvulsant and sedative effects of leaf extracts of Stachytarpheta 
cayennensis. J Trop Med Plants 2008; 9 (1): 17-22.
[10]Trease GE, Evans WC. Text book of pharmacognosy. 15th ed 
London: WB Saunders Company Ltd; 2001, p.33.
[11]Harbone JB. Phytochemical Methods: a guide to modern techniques 
of plant analysis. 2nd ed. London: Chapman and Hall;1988, p. 55-6.
[12]Bauer AW, Kirby MDK, Sherris JC, Truck M. Antibiotic 
susceptibility testing by a standardized single disc diffusing method. 
American Journal of Clinical Pathology 1996;45:493-6.
[13]Lovian V. Antibiotics in Laboratory Medicine. Baltimore: Williams 
and Williams;1980, p.7.
[14]Mukherjee PK. Quality Control of Herbal Drugs. (An Approach to 
Evaluation of Botanicals). New Delhi:Business Horizon Publishers; 
2007,p.570-5.
[15]Akah PA, Okoli CO, Ndu OO. Experimental Methods in Physiology 
and Pharmacology. Enugu:ABIC Books;2007,p.75-88.
[16]Balaji P, Bharath P, Satyan RS, Hariharan GN. In vitro 
antimicrobial activity of Roccella montagnei thallus extracts.  J Trop 
Med Plants 2006;7(2):169-71.
[17]Nwankwoala RNP, Wariso JF. The antimicrobial effects 
o f  Alant isore  PG 100.  West  Af r  J  Pharmacol  Drug Res 
1998;14(1&2):31-4.
[18]Offiah VN, Akah PA, Isizoh AO. Spasmolytic Activity of 
Cissampelous Mucromata Leaf Extract.  Phythotherapy Research, 
1996;10: 322-4.
[19]Hassan HS, Haruna AK, Hassan AS, Aguru A, Musa KY. 
Phytochemical an antispasmodic studies of the fruits of Solanum gilo 
Nig. J Nat Prod And Med 2006;10:45-6.
[20]Macander PJ. Flavoniods affect of acetylcholine, prostaglanding 
E. and antigen induced smooth muscle contraction. Prog Clin Biol 
Res1986;231:489-92.
[21]Capasso FA, Pinto A, Mascolo N, Autore G, France MP.  Effect of 
flavonoids on PGE2- and LTD4- induced contractions on the guinea 
pig isolated ileum. Pharmacol Res Commun 1998; 20(suppl.1):204-
10.
